Readers chastise health officials for not speaking out earlier, urge a slower reopening for New York City and propose a national day of mourning.
The Biden administration has yet to name a permanent chief of the Food and Drug Administration, amid a deep review of potential treatments and vaccines against the coronavirus.
As the U.S. confronted a new wave of infection and death through the summer and fall, the president’s approach to the pandemic came down to a single question: What would it mean for him?
After months of caving to pressures from the White House, Commissioner Stephen Hahn and a band of agency scientists have eked out a few victories.
Downplaying the dangers of the pandemic and politicizing public health measures was grossly negligent and cost untold lives.
Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the government’s response to the pandemic.
The F.D.A. proposed stricter guidelines for emergency approval of a coronavirus vaccine, but the White House chief of staff objected to provisions that would push approval past Election Day.
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
A group of career scientists at the Food and Drug Administration vowed that their work would continue unimpeded and independent of political influence.
The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.
Stephen Hahn made misleading remarks about a coronavirus treatment. How did that happen?
Many experts — including a scientist who worked on the Mayo Clinic study — were bewildered about where a key statistic came from.
Sowing doubt about the safety of treatments will imperil the fight against coronavirus in the months and years to come.
The move came on the eve of the Republican convention and after President Trump pressed the agency to move faster to address the pandemic.
Many medical experts — including members of his own staff — worry about whether Dr. Hahn has the fortitude and political savvy to protect the scientific integrity of the F.D.A. from Mr. Trump.
A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel when reviewing data on coronavirus trials.
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have shown whether the therapy worked.
Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials — hampering research that would have showed whether the therapy worked.
Operation Warp Speed has moved along at a rapid clip. But some people involved in the approval process fear pressure to deliver an October surprise for President Trump.
Despite progress on a vaccine, there is no guarantee it will be effective, experts said, and testing and contact tracing are still short of the levels needed.
At a news conference, the president reiterated that he would not wear a mask himself and again exaggerated the availability of testing for the coronavirus.
Tuesday’s hearing before the Senate Health Committee will be a chance for Dr. Anthony S. Fauci and other top health experts to speak to lawmakers, albeit by video, without President Trump nearby.
The drugs, hydroxychloroquine and chloroquine, have been repeatedly promoted by President Trump. But they should be used only in clinical trials or hospitals, the agency said.
Aggressive screening might have helped contain the coronavirus in the United States. But technical flaws, regulatory hurdles and lapses in leadership let it spread undetected for weeks.
The president cites “tremendous promise” for existing drugs, but their use against the new virus is unproven.